ey0018.6-10 | Patient Related Outcomes | ESPEYB18
Duranteau Lise , Rapp Marion , van de Grift Tim C , Hirschberg Angelica L
ey0018.7-5 | Clinical Guidance | ESPEYB18
EV Brauner , AS Busch , C Eckert-Lind , T Koch , M Hickey , A Juul
ey0018.8-6 | Important for Clinical Practice | ESPEYB18
AL Hirschberg , S Gidlof , H Falhammar , L Frisen , C Almqvist , A Nordenskjold , A Nordenstrom
ey0018.9-1 | Cancer treatment and the risk of second neoplasia | ESPEYB18
NMY Journy , WS Zrafi , S Bolle , B Fresneau , C Alapetite , RS Allodji , D Berchery , N Haddy , I Kobayashi , M Labbe , H Pacquement , C Pluchart , B Schwartz , V Souchard , C Thomas-Teinturier , C Veres , G Vu-Bezin , I Diallo , F de Vathaire
ey0018.9-12 | Cancer treatment, growth and growth hormone therapy | ESPEYB18
SR Rose , M Carlsson , A Grimberg , F Aydin , A Albanese , ACS Hokken-Koelega , C Camacho-Hubner
ey0018.10-11 | (1) | ESPEYB18
H Thabit , JN Prabhu , W Mubita , C Fullwood , S Azmi , A Urwin , I Doughty , L Leelarathna
ey0018.11-9 | Review and recommendations on ROHHAD(NET) Syndrome | ESPEYB18
J Harvengt , C Gernay , M Mastouri , N Farhat , MC Lebrethon , MC Seghaye , V Bours
ey0018.11-11 | Criticism of the previous BMI metrics for use in severely obese children | ESPEYB18
SE Barlow , M Salahuddin , C Durand , SJ Pont , DM Hoelscher , NF Butte
ey0018.12-7 | Type 2 Diabetes | ESPEYB18
RA Delicano , U Hammar , A Egenvall , C Westgarth , M Mubanga , L Byberg , T Fall , B Kennedy
ey0019.2-1 | Neonatal hypoglycaemia | ESPEYB19
K Gupta , P Amboiram , U Balakrishnan , A C , T Abiramalatha , U Devi